Immunology eNewsletter


Immunology Newsletter

l  Cell Therapy 연구에 최적화 GMP Protein!

l  신제품! Mouse Apoptosis Antibody Array Kit

l  Biosimilar Antibody & Anti-Idiotype Antibody





GMP Proteins


GMP Proteins for Therapeutic Manufacturing


R&D Systems® 에서 GMP cytokines growth factor 출시했습니다. 제품들은 cell therapy 연구에 사용할 있도록 USP Chapter <1043>, USP Chapter <92> 따라 만들어졌습니다.

View Brochure






Mouse Apoptosis Array


New Proteome Profiler Mouse Apoptosis Array


Mouse Apoptosis Antibody Array Kit 출시됐습니다!

하나의 Cell lysate에서 21개의 apoptosis marker 확인할 있습니다.

View Product






Anti-Idiotype Antibodies


R&D Systems Now Offers Biosimilar and Anti-Idiotype Antibodies


최근antibody drug 개발이 활발히 진행됨에 따라, R&D Systems에서 antibody drug 연구에 사용할 있는 antibody들을 출시했습니다. Biosimilar target으로 하는 제품들과 Anti-Idiotype antibody 제품 list 확인해보세요.

Learn More






Immune checkpoint


Immune Checkpoint Inhibitors from Tocris


Immune checkpoint molecules immunosuppressive signaling pathway 관련된 immune cell receptor inhibition합니다. Tocris (D)-PPA 1, 비롯하여 PD-L1/PD-1 interaction blocker, tumor growth inhibitor 다양한 small molecule들을 출시하고 있습니다.

Learn More






Biotinylated Proteins


New Biotinylated Proteins: Specificity Backed by Activity Data


R&D Systems에서 immuno-oncology 관련 biotinylated cytokine들을 출시했습니다. Biotinylated IL-2, IL-6, VISTA, VSIG4, PD-L2 다양한 제품들의 activity data 확인해 보세요.

View Product Listing






Immuno-Oncology Research


Explore Our Collection of Products for Immuno-Oncology Research


새로운 immune checkpoint regulator들이 알려지면서 cancer immunotherapy 새로운 target 되지 않을까 하는 기대감이 높아지고 있습니다. 어떤regulator들이 있는지, 연구에 사용할 있는 제품들은 어떤 것들이 있는지, R&D systems에서 발간한 Immuno-Oncology Brochure 통해서 확인해보세요.
View Brochure






Targeting MDSCs


Targeting MDSCs for Cancer Immunotherapy


Myeloid-derived suppressor cells (MDSCs) immunosuppressive 특징을 가지기 때문에 cancer 치료에 있어서 장애물로 여겨집니다. R&D systems blog 에서 MDSCs target으로 하는 최신 연구 동향 등을 살펴보세요.

Read Our Blog






MAPK Signaling Pathways


New Poster: Refresh Your MAPK Signaling Expertise


MAPK signaling dysfunction carcinogenesis 연관 있습니다. 최근 MAPK signaling inhibition tumor immune response cancer immunotherapy 연구자들 사이에서 화제가 되고 있습니다. MAPK signaling poster 통해 key marker 확인해 보세요.

View Poster






IL-10 Cytokines


New! IL-10 Cytokine Family Signaling Pathways


IL-10 pro-tumorigenic anti-tumorigenic 효과를 보이는 cytokine으로 알려져 있습니다. IL-10 signaling pathway 통해 IL-10 cytokine 관련된 family cytokine들이 어떤 상호작용을 하는지 확인해 보세요.

Explore Now



제품 상담 : 학술마케팅팀 한소영 ( / 02-881-5432 내선 731)

사이트명 :(주)웅비메디텍 / 상호:(주)웅비메디텍
전화: 02-881-5432 / FAX: 02-881-5454
서울특별시 송파구 송파대로201동 테라타워A동 1113호 (문정동642번지)
CopyrightⓒAll Rights Reserved Any questions to

-2018년 08월 27일-

Single Cell isolation Smart Aliquotor Single-Cell Isolation Easy to operate with high efficiency Exellent integrity for  PCR and sequencing Single-Cell Cloning High viability and high efficiency Easy to track whole cloning process Rare Cell Isolation From gene edited cells(i.e CRISPR) From clinical samples (i.e.blood) Single-Cell PCR sigle-cell isolation and identification in situ lysis of identified single cell transfer of lysate into PCR tube cDNA synthesis and amplification Operation is very simple Only a common pipette is needed  for use and takes about 15 seconds Excellent cell compatibility It is compatible with isolation of cells that have diameters less than 5μm. High yield and viability One Smart Aliquotor yields about  30 single cells, Which have high viability. Identifiable and selectable Each single can be easily identified and then selected. Features Operation by common pipettes Cell size ≤ 50μm idiameter Cloning in-situ clonal generation Single-cell yield ~30 cells per device Identification 1 well per second Time in aliquoting ~15 seconds Required cell numbers ≥2cells Minimum aliquot volume 50nL Comparison of Single-Cell Isolation Methods Capability/Specifics Serial Dilution Micro- manipulation Flow Cytometry SMART ALIQUOTOR Simplicity and time consumption Controllability in transfer volume Compatibility in rare cell isolation Compatibility in cell size & shape Throughput Cell viability Cell selectivity Affordability